RESEARCH: INFLUENZA
FOLDING PROJECT #12441 PROFILE

Miniprotein drugs are being designed to fight flu viruses. These tiny proteins bind to a viral protein called hemagglutinin, stopping the virus from infecting cells. Scientists want to understand how these miniproteins work so they can design even better ones. They're using computer simulations to study how the miniproteins attach to and detach from hemagglutinin.

Note: This TLDR is a simplication and may not be 100% accurate.

Designed miniprotein therapeutics occupy the middle ground between small molecule drugs and monoclonal antibody treatments for infectious disease.

Hemagglutinin is a viral fusion protein that allows H1 influenza A (HA) to bind sialic acid on cell surfaces, as well as being involved in the post-endocytosis mechanism of cellular infection.; The Baker lab at University of Washington has developed de novo designed miniproteins that bind hemagglutinin, and developed ways to improve their binding through affinity maturation.

Many of the mutations seen in affinity-matured sequences are not directly in the binding interface, and it is unclear how these changes lead to higher affinity.

Understanding this mechanism may help us better computationally design better binders.

We aim to use molecular dynamics simulations to examine ab initio binding pathways for these miniprotein binders, and use enhanced sampling methods to study the unbinding reaction.

Pairing these methods together will provide a robust description of the complete binding reaction for this system.

---

miniproteins

Small, engineered proteins with specific functions.

Miniproteins are novel therapeutic agents smaller than traditional antibodies. They offer advantages like improved delivery and production efficiency. Research focuses on designing miniproteins to target specific diseases.

---

therapeutics

Agents used to treat or prevent diseases.

Therapeutics encompass a wide range of medical interventions aimed at treating or preventing diseases. They include drugs, biologics, gene therapies, and other innovative approaches.

---

infectious disease

A disease caused by pathogenic microorganisms.

Infectious diseases are illnesses resulting from the invasion and multiplication of harmful microorganisms like bacteria, viruses, fungi, or parasites within the body.

---

hemagglutinin

A viral protein that allows attachment to host cells.

Hemagglutinin is a crucial surface protein found on influenza viruses. It enables the virus to bind to and enter host cells, initiating infection.

---

H1 influenza A

Subtype of influenza A virus

H1N1 is a subtype of the influenza A virus. It is characterized by two specific surface proteins: hemagglutinin (H1) and neuraminidase (N1). This subtype has caused several pandemics throughout history.

---

sialic acid

A type of sugar molecule found on cell surfaces.

Sialic acid is a complex sugar molecule often attached to proteins and lipids on the surface of cells. It plays various roles in cellular recognition, signaling, and immune responses.

---

affinity maturation

Process of improving the binding affinity of antibodies.

Affinity maturation is a crucial step in antibody engineering. It involves introducing mutations into an antibody's DNA to enhance its ability to bind to a specific target with higher affinity and specificity.

---

molecular dynamics simulations

Computer models to simulate molecular movements and interactions.

Molecular dynamics simulations are computational tools used to study the behavior of molecules at an atomic level. They can predict how molecules interact with each other, their movement, and energy changes, aiding in drug design and understanding biological processes.

---

enhanced sampling methods

Techniques to accelerate molecular simulations.

Enhanced sampling methods are computational strategies used in molecular simulations to explore a wider range of molecular configurations and overcome the limitations of traditional simulation techniques. They allow researchers to study rare events and complex systems more efficiently.